Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the efficacy of continuous interscalene block (CISB) using standard bupivacaine versus a single interscalene injection of liposomal bupivacaine (LB) on pain control following surgical fixation of proximal humerus fractures.


Clinical Trial Description

Restricted range of motion following open reduction and internal fixation (ORIF) of proximal humerus fractures is a potential complication that severely limits functional outcomes . It must therefore be avoided by adequate pain control in order to allow for early mobilisation in addition to physiotherapy. Interscalene block (ISB) is one of the most effective and widely used regional analgesic options shoulder surgeries. ISB can be delivered as a single injection or by continuous infusion via an indwelling catheter. While continuous interscalene block (CISB) offers a longer duration of analgesia as compared to a single injection of the same anaesthetic, it carries an inherent risk of catheter malposition, dislodgement, and infection. As compared to standard bupivacaine (SB), liposomal bupivacaine (LB) is a formulation designed to prolong the duration of analgesia up to 72 hours via a single injection. While this could avoid the need for an indwelling catheter, results of studies comparing LB to CISB have been inconsistent. The purpose of this is non-inferiority trial is to compare the effectiveness of a single injection of LB versus CISB with SB on pain control following ORIF of proximal humerus fractures. The study hypothesis is that LB is not unacceptably worse than CISB with regard to pain control in the first two postoperative days. Patients providing informed consent will be screened for eligibility. All eligible patients will be randomly assigned in a double-blind manner (participant and investigator) and a 1:1 ratio to receive either LB or CISB. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05084573
Study type Interventional
Source The University of Hong Kong
Contact Chi Wing Chan
Phone 22551740
Email timmychancw@gmail.com
Status Recruiting
Phase Phase 3
Start date August 1, 2020
Completion date March 31, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04003272 - MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
Active, not recruiting NCT02944058 - Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures N/A
Withdrawn NCT00741182 - Effect of PTH(1-34) Treatment on Fracture Healing in Vivo Phase 2
Completed NCT03217344 - Conservative Treatment of Proximal Humeral Fractures N/A
Recruiting NCT02609906 - Operative Treatment of 2-fragment-fractures (AO 11-A3) of the Proximal Humerus in the Elderly: Cement Augmented Locking Plate Philos vs. Proximal Humerus Nail MultiLoc N/A
Active, not recruiting NCT05302089 - Rehabilitation Following Displaced Proximal Humerus Fractures N/A
Not yet recruiting NCT06416618 - Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years N/A
Completed NCT02836366 - Targon PH+ Follow-Up
Recruiting NCT01687374 - Parathyroid Hormone for the Treatment of Humerus Fractures Phase 4
Recruiting NCT04928664 - Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP) Phase 4
Completed NCT02539173 - Diagnosis of Diaphragmatic Paralysis After Interscalene Block: Feasibility and Impact Observed N/A
Recruiting NCT04984291 - Zimmer Biomet Shoulder Arthroplasty PMCF N/A
Not yet recruiting NCT06357143 - Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis N/A
Recruiting NCT02913378 - Conservative vs Surgical Treatment for Proximal Humerus Fractures in the Elderly N/A
Enrolling by invitation NCT04003311 - MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
Recruiting NCT04651543 - X-Ray Follow-up in Proximal Humeral Fractures Conservatively Treated
Not yet recruiting NCT04507880 - A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures N/A
Terminated NCT03599336 - RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures N/A
Recruiting NCT05284357 - Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term
Not yet recruiting NCT06360887 - Management of Proximal Humerus Fractures in Adults: a Clinical Trial